1094-76-4

Basic information

• Product Name: epsilon-dinitrophenyllysine
• Synonyms: epsilon-dinitrophenyllysine
• CAS NO: 1094-76-4
• Molecular Formula: C₁₂H₁₆N₄O₆
• Molecular Weight: 312.2786
• Mol File: 1094-76-4.mol

Chemical Properties

• Boiling Point: 571.6°Cat760mmHg
• Flash Point: 299.5°C
• Appearance: /
• Density: 1.46g/cm³
• Vapor Pressure: 6.6E-14mmHg at 25°C
• Refractive Index: 1.641
• CAS DataBase Reference: epsilon-dinitrophenyllysine(CAS DataBase Reference)
• NIST Chemistry Reference: epsilon-dinitrophenyllysine(1094-76-4)
• EPA Substance Registry System: epsilon-dinitrophenyllysine(1094-76-4)

Safety Data

• Hazardous Substances Data: 1094-76-4(Hazardous Substances Data)

Usage

Uses

Used in Research Applications:
Epsilon-dinitrophenyllysine is used as a research tool for studying protein structure and function. Its unique chemical properties allow it to interact with proteins and other biomolecules, providing insights into their mechanisms of action.
Used in Analytical Chemistry:
Epsilon-dinitrophenyllysine is used as an analytical reagent in various assays and tests. Its ability to bind to specific molecules makes it a valuable component in detecting and quantifying the presence of certain substances.
Used in Pharmaceutical Development:
Epsilon-dinitrophenyllysine has potential applications in the development of new pharmaceuticals. Its interaction with proteins and other biomolecules may lead to the discovery of novel therapeutic agents for various diseases and conditions.
Used in Environmental Monitoring:
Epsilon-dinitrophenyllysine can be used in environmental monitoring to detect the presence of pollutants or contaminants. Its binding properties make it a useful tool for identifying and quantifying harmful substances in the environment.

InChI:InChI=1/C12H16N4O6/c13-9(12(17)18)3-1-2-6-14-10-5-4-8(15(19)20)7-11(10)16(21)22/h4-5,7,9,14H,1-3,6,13H2,(H,17,18)/t9-/m0/s1

Upstream product

• 22619-87-0 N²-acetyl-N⁶-(2,4-dinitro-phenyl)-L-lysine 
• 70-34-8 2,4-Dinitrofluorobenzene 
• 1202639-03-9 C₂₁H₂₄N₄O₁₀S 
• 1202639-01-7 C₂₂H₂₆N₄O₁₀S 
• 1346693-90-0 C₃₆H₄₁N₅O₁₁S 
• 1346693-89-7 C₃₄H₃₇N₅O₁₂S 
• 1346693-88-6 C₃₄H₃₇N₅O₁₁S 
• 1346693-87-5 C₃₅H₃₉N₅O₁₁S 
• 1346693-86-4 C₃₃H₃₅N₅O₁₁S 
• 1346693-85-3 C₃₃H₃₄ClN₅O₁₁S 
• 1202639-17-5 C₂₃H₂₄N₆O₁₀ 
• 1202638-76-3 C₁₄H₁₅NO₇S 
• 14401-10-6 Nε-2,4-dinitrophenyl-L-lysine hydrochloride 
• 1202639-20-0 C₃₃H₂₉BrN₄O₈ 

Downstream Products

• 929540-21-6 C₄₆H₆₃N₅O₁₇ 

Relevant articles and documents

A peptide-based fluorescent probe images ERAAP activity in cells and in high throughput assays

ERAAP is an intracellular amino-peptidase that plays a central role in determining the repertoire of peptides displayed by cells by MHC class I molecules, and dysfunctions in ERAAP are linked to a variety of diseases. There is therefore great interest in developing probes that can image ERAAP in cells. In this report we present a fluorescent probe, termed Ep, that can image ERAAP activity in live cells. Ep is composed of a 10 amino acid ERAAP substrate that has a donor quencher pair conjugated to it, composed of BODIPY and dinitro-toluene. Ep undergoes a 20-fold increase in fluorescence after ERAAP cleavage, and was able to image ERAAP activity in cell culture via fluorescence microscopy. In addition, we used Ep to develop a high throughput screen for ERAAP inhibitors, and screened an electrophile library containing 1460 compounds. From this Ep based screen we identified aromatic alkyne-ketone as a lead fragment that can irreversibly inhibit ERAAP activity. We anticipate numerous applications of Ep given its unique ability to image ERAAP within cells.

CONTROLLED DRUG RELEASE FROM SOLID SUPPORTS

The invention relates to solid supports useful in medical applications that provide controlled release of drugs, such as peptides, nucleic acids and small molecules. The drugs are covalently coupled to the solid support through a linkage that releases the drug or a prodrug through controlled beta elimination.

CONTROLLED RELEASE FROM MACROMOLECULAR CONJUGATES

The invention relates to conjugates of macromolecular carriers and drugs comprising linkers that release the drug or a prodrug through rate-controlled beta-elimination, and methods of making and using the conjugates.

HIGHLY AFFINE COSMETIC AGENT

The invention relates to a cosmetic agent which is made essentially of a peptide linker and at least one cosmetic active ingredient which is covalently connected thereto.

Synthesis and application of unprotected cyclic peptides as building blocks for peptide dendrimers

We describe an efficient regiospecific method for cyclization of unprotected peptide segments based on intramolecular transthioesterification of unprotected cysteinyl peptide thioesters under the control of ring-chain tautomeric equilibrium in aqueous buf